3Lisa de las Fuentes,Pilar Herrero,Linda R. Peterson,Daniel P. Kelly,Robert J. Gropler,Víctor G. Dávila-Román.Myocardial Fatty Acid Metabolism: Independent Predictor of Left Ventricular Mass in Hypertensive Heart Disease[J].Hypertension: Journal of the American Heart Association.2003(1)
4van Bilsen M,PJ Smeets,AJ Gilde,van der Vusse GJ.Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?[].Cardiovascular Research.2004
2Ingwall JS, Poole-wilson PA, Coluccl WS, et al . ATP synthesis in the normal and failing heart[A]. Heart failure[M].USA: Churchill Livigstone, 1997.75-85.
3Lenflant C. Report for the task force on research in heart failure[J]. Circulation, 1994,90: 1118.
4Katz A. The myocardium in congestive heart failure[J]. Am J Cardiol, 1989,63:12A-16A.
5Osorio JC, Stanley WC, Linke A, et al . Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-a in pacing-induced heart failure[J]. Circulation,2002, 106: 606-612.
6Geltman EM, Smith JL, Beecher D, et al . Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography[J]. Am J Med, 1983, 74: 773-785.
7Davila Roman VG, Vedala G, Herrero P, et al . Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy[J]. J Am Coll Cardiol, 2002, 40: 271-277.
8Murakami Y, Zhang J, Eijgelshoven MH, et al . Myocardial creatine kinase kinetics in hearts with postinfarction left ventricular remodeling[J]. Am J Physiol, 1999, 276: H892-H900.
9Sanbe A, Tanonaka K, Kobayasi R, et al . Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction[J]. J Mol Cell Cardiol, 1995, 27: 2209-2222.
10Shen W, Asai K, Uechi M, et al . Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine[J]. Circulation, 1999, 100: 2113-2118.
5Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis [J]. Circulation,2004,109 (23 Suppl 1):Ⅲ27-32.
6Mulvihill EE, Huff MW. Citrus flavonoids and the prevention of ath-eroselerosis [J]. Cardiovasc Hematol Disord Drug Targets, 2012,12 (2):84-91.
7Davignon J. Beneficial cardiovascular pleiotropic effects of statins [J]. Circulation,2004,109 (23 Suppl 1):Ⅲ39-43.
8Fihn SD, GaMin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/ AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease:a report of the Ameri-can College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physi-cians,American Association for Thoracic Surgery, Preventive Cardio-vascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons [J]. Circulation, 2012,126(25):e354-e471.
9Trcmaroli V, Backhed F. Functional interactions between the gut mi-crobiota and host metabolism [J]. Nature, 2012,489 (7415):242-249.
10Stock J. Gut microbiota:an environmental risk factor for cardiovascu-lar disease [J]. Atherosclerosis ,2013,229 (2):440-442.
